Herantis Pharma OYJ

Helsinki, June 11, 2014

 NASDAQ OMX (NASDAQ: NDAQ) announced that trading in Herantis Pharma Plc (HRTIS) shares commenced today on First North Finland. The company belongs to the Health Care sector. First North Finland is a Multilateral Trading Facility (MTF) aimed towards emerging growth companies and has been operated by NASDAQ OMX Helsinki since April 4, 2011. 

Herantis Pharma Plc is a pharmaceutical company specialised in advancing scientific research into clinical research aiming at developing new drugs. The company focuses on diseases with an unmet clinical need. These diseases include for example dry eye syndrome, Parkinson’s disease, and secondary lymphedema. For more information, visit www.herantis.com


CEO Pekka Simula of Herantis Pharma Plc

Lauri Rosendahl welcomes Pekka Simula, CEO of Herantis Pharma to the Exchange

Pekka Simula, Lauri Rosendahl, Pekka Mattila (Chairman of the Board of Herantis Pharma) and Aki Prihti (Director of the Board) at the NASDAQ OMX Helsinki

Pekka Simula rings the bell